0001209191-20-056066.txt : 20201028 0001209191-20-056066.hdr.sgml : 20201028 20201028141225 ACCESSION NUMBER: 0001209191-20-056066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201026 FILED AS OF DATE: 20201028 DATE AS OF CHANGE: 20201028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schoenberg Mark CENTRAL INDEX KEY: 0001763581 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 201267795 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA TA ASIYA STREET CITY: RA ANANA STATE: L3 ZIP: 4365007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-26 0 0001668243 UroGen Pharma Ltd. URGN 0001763581 Schoenberg Mark 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 0 1 0 0 Chief Medical Officer Ordinary Shares 2020-10-26 4 M 0 208 A 19444 D Ordinary Shares 2020-10-26 4 S 0 101 20.9461 D 19343 D Restricted Stock Units 2020-10-26 4 M 0 208 0.00 D Ordinary Shares 208 1042 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. /s/ Jason Smith, Attorney-in-Fact 2020-10-28